Literature DB >> 19352323

Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neurons.

Pier Paolo Peruzzi1, Sean E Lawler, Steve L Senior, Nina Dmitrieva, Pauline A H Edser, Davide Gianni, E Antonio Chiocca, Richard Wade-Martins.   

Abstract

The microtubule-associated protein tau (MAPT) and alpha-synuclein (SNCA) genes play central roles in neurodegenerative disorders. Mutations in each gene cause familial disease, whereas common genetic variation at both loci contributes to susceptibility to sporadic neurodegenerative disease. Here, we demonstrate exquisite gene regulation of the human MAPT and SNCA transgene loci and functional complementation in neuronal cell cultures and organotypic brain slices using the herpes simplex virus type 1 (HSV-1) amplicon-based infectious bacterial artificial chromosome (iBAC) vector to express complete loci >100 kb. Cell cultures transduced by iBAC vectors carrying a 143 kb MAPT or 135 kb SNCA locus expressed the human loci similar to the endogenous gene. We focused on analysis of the iBAC-MAPT vector carrying the complete MAPT locus. On transduction into neuronal cultures, multiple MAPT transcripts were expressed from iBAC-MAPT under strict developmental and cell type-specific control. In primary neurons from Mapt(-/-) mice, the iBAC-MAPT vector expressed the human tau protein, as detected by enzyme-linked immunosorbent assay and immunocytochemistry, and restored sensitivity of Mapt(-/-) neurons to Abeta peptide treatment in dissociated neuronal cultures and in organotypic slice cultures. The faithful retention of gene expression and phenotype complementation by the system provides a novel method to analyze neurological disease genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352323      PMCID: PMC2835262          DOI: 10.1038/mt.2009.64

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  49 in total

1.  alpha-Synuclein locus triplication causes Parkinson's disease.

Authors:  A B Singleton; M Farrer; J Johnson; A Singleton; S Hague; J Kachergus; M Hulihan; T Peuralinna; A Dutra; R Nussbaum; S Lincoln; A Crawley; M Hanson; D Maraganore; C Adler; M R Cookson; M Muenter; M Baptista; D Miller; J Blancato; J Hardy; K Gwinn-Hardy
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro.

Authors:  M Pizzi; A Valerio; M Belloni; V Arrighi; A Alberici; P Liberini; P Spano; M Memo
Journal:  Brain Res Mol Brain Res       Date:  1995-12-01

3.  Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Authors:  Lisa Skipper; Kristen Wilkes; Mathias Toft; Matthew Baker; Sarah Lincoln; Mary Hulihan; Owen A Ross; Mike Hutton; Jan Aasly; Matthew Farrer
Journal:  Am J Hum Genet       Date:  2004-08-03       Impact factor: 11.025

4.  Tau isoform regulation is region- and cell-specific in mouse brain.

Authors:  Pamela McMillan; Elena Korvatska; Parvoneh Poorkaj; Zana Evstafjeva; Linda Robinson; Lynne Greenup; James Leverenz; Gerard D Schellenberg; Ian D'Souza
Journal:  J Comp Neurol       Date:  2008-12-20       Impact factor: 3.215

5.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

Authors:  Marie-Christine Chartier-Harlin; Jennifer Kachergus; Christophe Roumier; Vincent Mouroux; Xavier Douay; Sarah Lincoln; Clotilde Levecque; Lydie Larvor; Joris Andrieux; Mary Hulihan; Nawal Waucquier; Luc Defebvre; Philippe Amouyel; Matthew Farrer; Alain Destée
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

6.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

7.  Tau haplotypes regulate transcription and are associated with Parkinson's disease.

Authors:  John B J Kwok; Erdahl T Teber; Clement Loy; Marianne Hallupp; Garth Nicholson; George D Mellick; Daniel D Buchanan; Peter A Silburn; Peter R Schofield
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

8.  More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.

Authors:  Virginia M-Y Lee; Benoit I Giasson; John Q Trojanowski
Journal:  Trends Neurosci       Date:  2004-03       Impact factor: 13.837

9.  Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells.

Authors:  R Inoue; K A Moghaddam; M Ranasinghe; Y Saeki; E A Chiocca; R Wade-Martins
Journal:  Gene Ther       Date:  2004-08       Impact factor: 5.250

10.  The structure of the tau haplotype in controls and in progressive supranuclear palsy.

Authors:  Alan M Pittman; Amanda J Myers; Jaime Duckworth; Leslie Bryden; Melissa Hanson; Patrick Abou-Sleiman; Nicholas W Wood; John Hardy; Andrew Lees; Rohan de Silva
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

View more
  7 in total

Review 1.  Genetic therapy for the nervous system.

Authors:  William J Bowers; Xandra O Breakefield; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

2.  Microarray-assisted fine mapping of quantitative trait loci on chromosome 15 for susceptibility to seizure-induced cell death in mice.

Authors:  P E Schauwecker
Journal:  Eur J Neurosci       Date:  2013-09-03       Impact factor: 3.386

3.  Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.

Authors:  Keith A Vossel; Jordan C Xu; Vira Fomenko; Takashi Miyamoto; Elsa Suberbielle; Joseph A Knox; Kaitlyn Ho; Daniel H Kim; Gui-Qiu Yu; Lennart Mucke
Journal:  J Cell Biol       Date:  2015-05-11       Impact factor: 10.539

4.  Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse.

Authors:  Tonya N Taylor; Dawid Potgieter; Sabina Anwar; Steven L Senior; Stephanie Janezic; Sarah Threlfell; Brent Ryan; Laura Parkkinen; Thierry Deltheil; Milena Cioroch; Achilleas Livieratos; Peter L Oliver; Katie A Jennings; Kay E Davies; Olaf Ansorge; David M Bannerman; Stephanie J Cragg; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2013-10-10       Impact factor: 5.996

5.  Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy.

Authors:  Heike J Wobst; Franziska Denk; Peter L Oliver; Achilleas Livieratos; Tonya N Taylor; Maria H Knudsen; Nora Bengoa-Vergniory; David Bannerman; Richard Wade-Martins
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

6.  Haplotype-specific MAPT exon 3 expression regulated by common intronic polymorphisms associated with Parkinsonian disorders.

Authors:  Mang Ching Lai; Anne-Laure Bechy; Franziska Denk; Emma Collins; Maria Gavriliouk; Judith B Zaugg; Brent J Ryan; Richard Wade-Martins; Tara M Caffrey
Journal:  Mol Neurodegener       Date:  2017-10-30       Impact factor: 14.195

7.  The Efficacy of Graphene Foams for Culturing Mesenchymal Stem Cells and Their Differentiation into Dopaminergic Neurons.

Authors:  Nishat Tasnim; Vikram Thakur; Munmun Chattopadhyay; Binata Joddar
Journal:  Stem Cells Int       Date:  2018-06-03       Impact factor: 5.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.